Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | XDH | P47989 | 1/20 | 0.50 |
| ▸ | GFER | P55789 | 1/20 | 0.50 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.50 |
| ▸ | RELA | Q04206 | 1/20 | 0.50 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13524799 | 0.89 | ALDH1A1 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7718881 | 0.89 | SLC7A5 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7013307 | 0.89 | ALDH1A1 (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL16010428 | 0.87 | NOTUM (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL31371278 | 0.87 | CA1 (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL16729319 | 0.87 | CA12 (0.44) | CA12CA1CA2CA7CA9 | |
| SCHEMBL31385453 | 0.87 | CA1 (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL762861 | 0.85 | CA12 (0.54) | CA12CA1CA2CA7CA9 | |
| SCHEMBL12944867 | 0.84 | KDM4E (0.42) | CA12CA1CA2CA7CA9 | |
| SCHEMBL16727002 | 0.83 | NOTUM (0.60) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117700955-B | Antibacterial PET film material and preparation method thereof | 佛山市奥川顺新材料实业有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117700955-A | Antibacterial PET film material and preparation method thereof | 佛山市奥川顺新材料实业有限公司 | 2024-03-15 | — | — | CN | claimed |
| CN-117700955-B | Antibacterial PET film material and preparation method thereof | 佛山市奥川顺新材料实业有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-117700955-A | Antibacterial PET film material and preparation method thereof | 佛山市奥川顺新材料实业有限公司 | 2024-03-15 | — | — | CN | disclosed |
| US-20220062323-A1 | BIVALENT TARGETED CONJUGATES | ARBUTUS BIOPHARMA CORPORATION (CA) | 2022-03-03 | — | — | US | disclosed |
| US-20220062323-A1 | BIVALENT TARGETED CONJUGATES | ARBUTUS BIOPHARMA CORPORATION (CA) | 2022-03-03 | — | — | US | disclosed |
| US-20220031847-A1 | THERAPEUTIC METHODS | GENEVANT SCIENCES GMBH (CH) | 2022-02-03 | — | — | US | disclosed |
| US-20220031847-A1 | THERAPEUTIC METHODS | GENEVANT SCIENCES GMBH (CH) | 2022-02-03 | — | — | US | disclosed |
| EP-3873530-A1 | THERAPEUTIC METHODS | Genevant Sciences GmbH (CH) | 2021-09-08 | — | — | EP | disclosed |
| EP-3873486-A1 | BIVALENT TARGETED CONJUGATES | Arbutus Biopharma Corporation (CA) | 2021-09-08 | — | — | EP | disclosed |
| CN-113365662-A | Method of treatment | 盖纳万科学有限公司 | 2021-09-07 | — | — | CN | disclosed |
| US-7585364-B2 | Quinacridone derivatives for pigment dispersions | AGFA GRAPHICS NV (BE) | 2009-09-08 | — | — | US | disclosed |
| US-7585364-B2 | Quinacridone derivatives for pigment dispersions | AGFA GRAPHICS NV (BE) | 2009-09-08 | — | — | US | disclosed |
| CN-101522828-A | Non-aqueous pigmented inkjet inks | AGFA GRAPHICS NV (BE) | 2009-09-02 | — | — | CN | disclosed |
| US-20080314285-A1 | Quinacridone Derivatives for Pigment Dispersions | AGFA GRAPHICS NV (BE) | 2008-12-25 | — | — | US | disclosed |
| US-20080314285-A1 | Quinacridone Derivatives for Pigment Dispersions | AGFA GRAPHICS NV (BE) | 2008-12-25 | — | — | US | disclosed |
| US-20080295734-A1 | a mixture of organic pigments, and a a dispersion synergist containing acid groups or salts | AGFA GRAPHICS NV (BE) | 2008-12-04 | — | — | US | disclosed |
| US-20080295734-A1 | a mixture of organic pigments, and a a dispersion synergist containing acid groups or salts | AGFA GRAPHICS NV (BE) | 2008-12-04 | — | — | US | disclosed |
| US-20080269381-A1 | a mixture of diketopyrrolopyrrole dyes, polymeric dispersants and a quinacridone derivative containing acid groups or salts | AGFA GRAPHICS NV (BE) | 2008-10-30 | — | — | US | disclosed |
| US-20080269381-A1 | a mixture of diketopyrrolopyrrole dyes, polymeric dispersants and a quinacridone derivative containing acid groups or salts | AGFA GRAPHICS NV (BE) | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080314285-A1 | Quinacridone Derivatives for Pigment Dispersions | RB1, NDUFS2, NDUFS6 | CA12 4151/4885CA1 4836/4885CA2 4224/4885 |
| US-20220062323-A1 | BIVALENT TARGETED CONJUGATES | ERBB2, PCNA, MRE11 | CA12 542/4885CA1 1594/4885CA2 1922/4885 |
| US-20220031847-A1 | THERAPEUTIC METHODS | NUP205, HNRNPH3, FUS | CA12 786/4885CA1 2020/4885CA2 2411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.